{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:21:17Z","timestamp":1792081277681,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000402","name":"Kay Kendall Leukaemia Fund","doi-asserted-by":"publisher","award":["KKL1378"],"award-info":[{"award-number":["KKL1378"]}],"id":[{"id":"10.13039\/501100000402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["302479Z23Z"],"award-info":[{"award-number":["302479Z23Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K99HL150218"],"award-info":[{"award-number":["K99HL150218"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["3385-19"],"award-info":[{"award-number":["3385-19"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","award":["RG-202211-02958"],"award-info":[{"award-number":["RG-202211-02958"]}],"id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The biological mechanisms that sustain the vast blood production required for healthy life remain incompletely understood. To search for cell intrinsic regulators of hematopoiesis, we perform a genome-wide in vivo hematopoietic stem and progenitor cell (HSPC)-based CRISPR knockout screen. We discover SAGA complex members, including\n                    <jats:italic>Tada2b<\/jats:italic>\n                    and\n                    <jats:italic>Taf5l<\/jats:italic>\n                    , as key regulators of hematopoiesis. Loss of\n                    <jats:italic>Tada2b<\/jats:italic>\n                    or\n                    <jats:italic>Taf5l<\/jats:italic>\n                    strongly inhibits hematopoiesis in vivo, causing a buildup of immature hematopoietic cells in the bone marrow. The SAGA complex deposits histone H3 lysine 9 acetylation (H3K9ac) and removes histone H2B ubiquitination (H2Bub). Loss of\n                    <jats:italic>Tada2b<\/jats:italic>\n                    leads to a reduction in H3K9ac levels and altered H2Bub enrichment in HSPCs, implicating disruption of SAGA complex activity. This is associated with upregulation of interferon pathway genes, reduced mitochondrial activity, and increased megakaryocyte progenitor cell commitment. Loss of these factors also enhances the cell outgrowth and the interferon pathway in an in vivo human myelodysplastic syndrome cell line model. In summary, this study identifies the SAGA complex as an important regulator of hematopoiesis.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-68465-6","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:24:43Z","timestamp":1769160283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3499-4309","authenticated-orcid":false,"given":"Archana","family":"Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Olender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-3429","authenticated-orcid":false,"given":"Masashi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"P\u00e1lovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Meaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-291X","authenticated-orcid":false,"given":"Satoshi","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Rizq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei Minn","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavor","family":"Bozhilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyomi J.","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-9974","authenticated-orcid":false,"given":"Joydeep","family":"Bhadury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Munson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Kai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rehwinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-8992","authenticated-orcid":false,"given":"Atushi","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-0831","authenticated-orcid":false,"given":"Tony","family":"Wyss-Coray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-6973","authenticated-orcid":false,"given":"Hiromitsu","family":"Nakauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-0151","authenticated-orcid":false,"given":"Adam C.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"68465_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.273.5272.242","volume":"273","author":"M Osawa","year":"1996","unstructured":"Osawa, M., Hanada, K., Hamada, H. & Nakauchi, H. Long-term lymphohematopoietic reconstitution by a single CD34-low\/negative hematopoietic stem cell. Science 273, 242\u2013245 (1996).","journal-title":"Science"},{"key":"68465_CR2","doi-asserted-by":"publisher","unstructured":"Wilkinson, A.C., Igarashi, K.J., and Nakauchi, H. Haematopoietic stem cell self-renewal in vivo and ex vivo. Nat. Rev. Genet. https:\/\/doi.org\/10.1038\/s41576-020-0241-0 (2020).","DOI":"10.1038\/s41576-020-0241-0"},{"key":"68465_CR3","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","volume":"125","author":"CJ Eaves","year":"2015","unstructured":"Eaves, C. J. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 125, 2605\u20132613 (2015).","journal-title":"Blood"},{"key":"68465_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison, S. J. & Scadden, D. T. The bone marrow niche for haematopoietic stem cells. Nature 505, 327\u2013334 (2014).","journal-title":"Nature"},{"key":"68465_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature25022","volume":"553","author":"E Laurenti","year":"2018","unstructured":"Laurenti, E. & G\u00f6ttgens, B. From haematopoietic stem cells to complex differentiation landscapes. Nature 553, 418\u2013426 (2018).","journal-title":"Nature"},{"key":"68465_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.seminhematol.2008.07.010","volume":"45","author":"R Gazit","year":"2008","unstructured":"Gazit, R., Weissman, I. L. & Rossi, D. J. Hematopoietic stem cells and the aging hematopoietic system. Semin. Hematol. 45, 218\u2013224 (2008).","journal-title":"Semin. Hematol."},{"key":"68465_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2017-06-746412","volume":"131","author":"G de Haan","year":"2018","unstructured":"de Haan, G. & Lazare, S. S. Aging of hematopoietic stem cells. Blood 131, 479\u2013487 (2018).","journal-title":"Blood"},{"key":"68465_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2008.01.036","volume":"132","author":"DJ Rossi","year":"2008","unstructured":"Rossi, D. J., Jamieson, C. H. & Weissman, I. L. Stems cells and the pathways to aging and cancer. Cell 132, 681\u2013696 (2008).","journal-title":"Cell"},{"key":"68465_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-94-007-6621-1_11","volume":"786","author":"AC Wilkinson","year":"2013","unstructured":"Wilkinson, A. C. & Gottgens, B. Transcriptional regulation of haematopoietic stem cells. Adv. Exp. Med. Biol. 786, 187\u2013212 (2013).","journal-title":"Adv. Exp. Med. Biol."},{"key":"68465_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","volume":"132","author":"SH Orkin","year":"2008","unstructured":"Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631\u2013644 (2008).","journal-title":"Cell"},{"key":"68465_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1101\/gad.341156.120","volume":"34","author":"JHM Soffers","year":"2020","unstructured":"Soffers, J. H. M. & Workman, J. L. The SAGA chromatin-modifying complex: the sum of its parts is greater than the whole. Genes Dev. 34, 1287\u20131303 (2020).","journal-title":"Genes Dev."},{"key":"68465_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41594-021-00682-7","volume":"28","author":"DA Herbst","year":"2021","unstructured":"Herbst, D. A. et al. Structure of the human SAGA coactivator complex. Nat. Struct. Mol. Biol. 28, 989\u2013996 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"68465_CR13","doi-asserted-by":"publisher","unstructured":"Domingues, A.F. et al. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells. Elife 9, https:\/\/doi.org\/10.7554\/eLife.51754 (2020).","DOI":"10.7554\/eLife.51754"},{"key":"68465_CR14","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis, K. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17, 1193\u20131205 (2016).","journal-title":"Cell Rep."},{"key":"68465_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq2061","volume":"7","author":"N Dietlein","year":"2022","unstructured":"Dietlein, N. et al. Usp22 is an intracellular regulator of systemic emergency hematopoiesis. Sci. Immunol. 7, eabq2061 (2022).","journal-title":"Sci. Immunol."},{"key":"68465_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nbt.3659","volume":"34","author":"R Barrangou","year":"2016","unstructured":"Barrangou, R. & Doudna, J. A. Applications of CRISPR technologies in research and beyond. Nat. Biotechnol. 34, 933\u2013941 (2016).","journal-title":"Nat. Biotechnol."},{"key":"68465_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10652-9","volume":"10","author":"CC Bell","year":"2019","unstructured":"Bell, C. C. et al. Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia. Nat. Commun. 10, 2723 (2019).","journal-title":"Nat. Commun."},{"key":"68465_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ccell.2018.01.012","volume":"33","author":"T Yamauchi","year":"2018","unstructured":"Yamauchi, T. et al. Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS. Cancer Cell 33, 386\u2013400 e385 (2018).","journal-title":"Cancer Cell"},{"key":"68465_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrg.2017.97","volume":"19","author":"JG Doench","year":"2018","unstructured":"Doench, J. G. Am I ready for CRISPR? A user\u2019s guide to genetic screens. Nat. Rev. Genet. 19, 67\u201380 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"68465_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature25168","volume":"553","author":"AE Rodriguez-Fraticelli","year":"2018","unstructured":"Rodriguez-Fraticelli, A. E. et al. Clonal analysis of lineage fate in native haematopoiesis. Nature 553, 212\u2013216 (2018).","journal-title":"Nature"},{"key":"68465_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41588-023-01471-2","volume":"55","author":"D Lara-Astiaso","year":"2023","unstructured":"Lara-Astiaso, D. et al. In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis. Nat. Genet. 55, 1542\u20131554 (2023).","journal-title":"Nat. Genet."},{"key":"68465_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-1244-x","volume":"571","author":"AC Wilkinson","year":"2019","unstructured":"Wilkinson, A. C. et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature 571, 117\u2013121 (2019).","journal-title":"Nature"},{"key":"68465_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOH.0000000000000593","volume":"27","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto, R., Wilkinson, A. C. & Nakauchi, H. In vivo and ex vivo haematopoietic stem cell expansion. Curr. Opin. Hematol. 27, 273\u2013278 (2020).","journal-title":"Curr. Opin. Hematol."},{"key":"68465_CR24","doi-asserted-by":"publisher","unstructured":"Igarashi, K. J. et al. Physioxia improves the selectivity of hematopoietic stem cell expansion cultures. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2023009668 (2023).","DOI":"10.1182\/bloodadvances.2023009668"},{"key":"68465_CR25","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2016-12-689109","volume":"129","author":"M de Bruijn","year":"2017","unstructured":"de Bruijn, M. & Dzierzak, E. Runx transcription factors in the development and function of the definitive hematopoietic system. Blood 129, 2061\u20132069 (2017).","journal-title":"Blood"},{"key":"68465_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nm997","volume":"10","author":"M Ichikawa","year":"2004","unstructured":"Ichikawa, M. et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10, 299\u2013304 (2004).","journal-title":"Nat. Med."},{"key":"68465_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1182\/blood-2004-08-3280","volume":"106","author":"JD Growney","year":"2005","unstructured":"Growney, J. D. et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106, 494\u2013504 (2005).","journal-title":"Blood"},{"key":"68465_CR28","doi-asserted-by":"publisher","unstructured":"Che, J.L.C. et al. Identification and characterization of in vitro expanded hematopoietic stem cells. EMBO Rep. e55502, https:\/\/doi.org\/10.15252\/embr.202255502 (2022).","DOI":"10.15252\/embr.202255502"},{"key":"68465_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.06.002","author":"HJ Becker","year":"2023","unstructured":"Becker, H. J. et al. Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion. Cell Stem Cell https:\/\/doi.org\/10.1016\/j.stem.2023.06.002 (2023).","journal-title":"Cell Stem Cell"},{"key":"68465_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1182\/bloodadvances.2020002842","volume":"6","author":"L Arede","year":"2022","unstructured":"Arede, L. et al. KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia. Blood Adv. 6, 165\u2013180 (2022).","journal-title":"Blood Adv."},{"key":"68465_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-023-05739-9","volume":"615","author":"M Sakurai","year":"2023","unstructured":"Sakurai, M. et al. Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature 615, 127\u2013133 (2023).","journal-title":"Nature"},{"key":"68465_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl1584","volume":"10","author":"MU Nguyen","year":"2024","unstructured":"Nguyen, M. U. et al. KAT2A and KAT2B prevent double-stranded RNA accumulation and interferon signaling to maintain intestinal stem cell renewal. Sci. Adv. 10, eadl1584 (2024).","journal-title":"Sci. Adv."},{"key":"68465_CR33","doi-asserted-by":"publisher","unstructured":"Batty, P. et al. Disruption of the SAGA CORE triggers collateral degradation of KAT2A. bioRxiv, https:\/\/doi.org\/10.1101\/2025.07.24.666361 (2025).","DOI":"10.1101\/2025.07.24.666361"},{"key":"68465_CR34","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nmeth.3542","volume":"12","author":"C Schmidl","year":"2015","unstructured":"Schmidl, C., Rendeiro, A. F., Sheffield, N. C. & Bock, C. ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors. Nat. Methods 12, 963\u2013965 (2015).","journal-title":"Nat. Methods"},{"key":"68465_CR35","doi-asserted-by":"publisher","unstructured":"Greenberg, P.L., Young, N.S., and Gattermann, N. (2002). Myelodysplastic syndromes. Hematol. Am. Soc. Hematol. Educ. Program 136\u2013161, https:\/\/doi.org\/10.1182\/asheducation-2002.1.136 (2002).","DOI":"10.1182\/asheducation-2002.1.136"},{"key":"68465_CR36","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1038\/s41375-018-0189-7","volume":"32","author":"JI Kida","year":"2018","unstructured":"Kida, J. I. et al. An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS. Leukemia 32, 1846\u20131850 (2018).","journal-title":"Leukemia"},{"key":"68465_CR37","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood.2024028033","volume":"146","author":"J Loke","year":"2025","unstructured":"Loke, J. et al. An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesis. Blood 146, 1174\u20131186 (2025).","journal-title":"Blood"},{"key":"68465_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23763-z","volume":"12","author":"K Ochi","year":"2021","unstructured":"Ochi, K., Morita, M., Wilkinson, A. C., Iwama, A. & Yamazaki, S. Non-conditioned bone marrow chimeric mouse generation using culture-based enrichment of hematopoietic stem and progenitor cells. Nat. Commun. 12, 3568 (2021).","journal-title":"Nat. Commun."},{"key":"68465_CR39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41596-019-0263-2","volume":"15","author":"AC Wilkinson","year":"2020","unstructured":"Wilkinson, A. C., Ishida, R., Nakauchi, H. & Yamazaki, S. Long-term ex vivo expansion of mouse hematopoietic stem cells. Nat. Protoc. 15, 628\u2013648 (2020).","journal-title":"Nat. Protoc."},{"key":"68465_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15178","volume":"8","author":"DW Morgens","year":"2017","unstructured":"Morgens, D. W. et al. Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens. Nat. Commun. 8, 15178 (2017).","journal-title":"Nat. Commun."},{"key":"68465_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20909-x","volume":"12","author":"AC Wilkinson","year":"2021","unstructured":"Wilkinson, A. C. et al. Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice. Nat. Commun. 12, 686 (2021).","journal-title":"Nat. Commun."},{"key":"68465_CR42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1182\/bloodadvances.2020001461","volume":"5","author":"K Kayamori","year":"2021","unstructured":"Kayamori, K. et al. DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes. Blood Adv. 5, 438\u2013450 (2021).","journal-title":"Blood Adv."},{"key":"68465_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68465-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:16:27Z","timestamp":1771344987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68465-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68465"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68465-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.N. is a co-founder of Celaid Therapeutics. A.C.W. is a consultant for ImmuneBRIDGE. However, none of these companies had input into the design, execution, interpretation, or publication of the work in this manuscript. No other authors declare competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1756"}}